Tenet (THC) Director Kerrey J. Robert Sells 12,010 Shares

What Happened
Kerrey J. Robert, a director of Tenet Healthcare Corporation (THC), sold a total of 12,010 shares in open-market transactions on September 14, 2026, generating approximately $3.17 million in proceeds. The sales were reported on a Form 4 filed September 16, 2026. The transactions were sales (not purchases), which are often routine insider liquidity events rather than a direct signal of company outlook.

Key Details

• Transaction date: September 14, 2026; Form 4 filed September 16, 2026 (timely within the usual 2‑business‑day reporting window).
• Trades (all sales, code S):
  • 5,483 shares sold at a weighted average price of $263.04; prices in that lot ranged $262.43–$263.37 (Footnote F1). Proceeds: $1,442,248.
  • 4,025 shares sold at a weighted average price of $264.10; prices ranged $263.45–$264.44 (Footnote F2). Proceeds: $1,063,003.
  • 2,502 shares sold at a weighted average price of $264.62; prices ranged $264.45–$265.02 (Footnote F3). Proceeds: $662,079.
• Total shares sold: 12,010; total proceeds: ~$3,167,330.
• Shares owned after the transactions: not specified in the summary data provided.
• Notable footnotes: each reported price is a weighted average of multiple sales and includes the price ranges for those trades (F1–F3). No indication in the provided excerpt of a 10b5‑1 plan, tax withholding, gift, or option exercise.

Context

• These were open‑market sales by a company director. Sales by insiders can be routine (diversification, liquidity, tax planning) and do not by themselves prove a change in company fundamentals.
• Filing appears timely. No derivatives, exercises, or awards were reported in the excerpt you provided.